S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?

BIOLASE Stock Price, News & Analysis (NASDAQ:BIOL)

$1.51
+0.36 (+31.30%)
(As of 12/4/2023 ET)
Compare
Today's Range
$1.19
$1.65
50-Day Range
$1.09
$1.89
52-Week Range
$1.07
$88.66
Volume
2.25 million shs
Average Volume
165,936 shs
Market Capitalization
$3.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$77.00

BIOLASE MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
4,999.3% Upside
$77.00 Price Target
Short Interest
Bearish
5.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.18mentions of BIOLASE in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.79 out of 5 stars


BIOL stock logo

About BIOLASE Stock (NASDAQ:BIOL)

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, therapy pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

BIOL Stock Price History

BIOL Stock News Headlines

BIOLASE (NASDAQ:BIOL) Lowered to "Sell" at StockNews.com
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
A Preview Of Biolase's Earnings
U.S. Military Defense Fails Without Vanadium?
The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply.
Biolase Inc BIOL
BIOLASE, Inc. (BIOL)
Here's Why BIOLASE Shares Were Volatile This Week
Why BIOLASE Stock Is Getting Obliterated Thursday
BIOLASE down 30%, prices $4.5M stock offering
Biolase Shares Plummet After Offering Prices
Q2 2023 BIOLASE Inc Earnings Call
Biolase: Q2 Earnings Snapshot
Here's what Wall Street expects from Biolase's earnings report
See More Headlines
Receive BIOL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
12/05/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/26/2024

Industry, Sector and Symbol

Industry
Dental equipment & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BIOL
Previous Symbol
NASDAQ:BLTI
Employees
188
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$77.00
High Stock Price Target
$150.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+4,999.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-28,630,000.00
Pretax Margin
-50.34%

Debt

Sales & Book Value

Annual Sales
$48.46 million
Book Value
$63.32 per share

Miscellaneous

Free Float
2,291,000
Market Cap
$3.47 million
Optionable
Not Optionable
Beta
1.16
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report














BIOL Stock Analysis - Frequently Asked Questions

Should I buy or sell BIOLASE stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BIOLASE in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BIOL shares.
View BIOL analyst ratings
or view top-rated stocks.

What is BIOLASE's stock price target for 2024?

2 Wall Street analysts have issued 12-month price targets for BIOLASE's stock. Their BIOL share price targets range from $4.00 to $150.00. On average, they anticipate the company's share price to reach $77.00 in the next twelve months. This suggests a possible upside of 4,999.3% from the stock's current price.
View analysts price targets for BIOL
or view top-rated stocks among Wall Street analysts.

How have BIOL shares performed in 2023?

BIOLASE's stock was trading at $65.00 on January 1st, 2023. Since then, BIOL stock has decreased by 97.7% and is now trading at $1.51.
View the best growth stocks for 2023 here
.

Are investors shorting BIOLASE?

BIOLASE saw a increase in short interest in November. As of November 15th, there was short interest totaling 100,500 shares, an increase of 1,068.6% from the October 31st total of 8,600 shares. Based on an average trading volume of 309,600 shares, the days-to-cover ratio is currently 0.3 days. Approximately 5.1% of the shares of the stock are short sold.
View BIOLASE's Short Interest
.

When is BIOLASE's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 26th 2024.
View our BIOL earnings forecast
.

How were BIOLASE's earnings last quarter?

BIOLASE, Inc. (NASDAQ:BIOL) released its quarterly earnings results on Thursday, November, 9th. The medical technology company reported ($3.89) earnings per share (EPS) for the quarter. The medical technology company earned $10.92 million during the quarter. BIOLASE had a negative trailing twelve-month return on equity of 503.34% and a negative net margin of 50.61%.

When did BIOLASE's stock split?

BIOLASE's stock reverse split on Friday, July 28th 2023. The 1-100 reverse split was announced on Friday, July 28th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What is John R. Beaver's approval rating as BIOLASE's CEO?

4 employees have rated BIOLASE Chief Executive Officer John R. Beaver on Glassdoor.com. John R. Beaver has an approval rating of 13% among the company's employees. This puts John R. Beaver in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 35.0% of employees surveyed would recommend working at BIOLASE to a friend.

What other stocks do shareholders of BIOLASE own?
Who are BIOLASE's major shareholders?

BIOLASE's stock is owned by many different institutional and retail investors. Top institutional shareholders include Walleye Capital LLC (0.74%). Insiders that own company stock include Education Foundation Schuler, John R Beaver, John R Beaver and Jonathan T Md Lord.
View institutional ownership trends
.

How do I buy shares of BIOLASE?

Shares of BIOL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:BIOL) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -